GL1X · GenesisL1 explorer

MolNFT v1 · #26625 · protein

Crystallographic studies on acyl ureas, a new class of inhibitors of glycogen phosphorylase. broad specificity of the allosteric site

1WV0 · Glycogen phosphorylase, muscle form: “Crystallographic studies on acyl ureas, a new class of inhibitors of glycogen phosphorylase. broad…”. X-ray diffraction, 2 ligands (PLP, BN4), 13 pockets (best druggability 0.85). MolNFT v1…

PDB
1WV0
Type
protein
Length
816 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
PLP, BN4
Pockets
13 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein81652% helix, 15% strandP00489

Ligands and binding sites

  • PLP · Pyridoxal-5'-phosphate · ligand · chains A
  • BN4 · 4-[4-({[(2,4-dichlorobenzoyl)amino]carbonyl}amino)-2,3-dimethylphenoxy]butanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12880.850.9655PLP
21460.790.9642empty
32840.700.8531empty
41620.520.7925empty
51130.520.8220empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1WV0 · Crystallographic studies on acyl ureas, a new class of inhibitors of glycogen… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.